The addition of HA was made after surgeon feedback indicated that bone ongrowth on all sides of the PEEK device could be more effective.
A pre-clinical Invibio study using a sheep model showed that within four weeks of implantation, the PEEK-OPTIMA HA Enhanced Polymer demonstrated enhanced bone apposition compared to PEEK-OPTIMA. After 12 weeks, the bone apposition levels are maintained with the new grade.
More Articles on Devices:
SI-BONE Reaches 25k Implantation Milestone for iFuse Device
Recently-Appointed InVivo Therapeutics Acting CFO Sean Moran Abruptly Resigns
Titan Spine Debuts Study Supporting its Device Surface Technology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
